Episode
Drugs for Migraine Prophylaxis
- Podcast
- Weekly Neurology Deep Dive - A review of recent impactful publications in the field of Neurology
- Published
- Jun 14, 2026
- Duration seconds
- 646
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/weekly-neurology-deep-dive-a-review-of-recent-impactful-publications-in-the-field-of-neurology-7345980/episodes/drugs-for-migraine-prophylaxis/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/weekly-neurology-deep-dive-a-review-of-recent-impactful-publications-in-the-field-of-neurology-7345980/drugs-for-migraine-prophylaxis.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
This medical review examines current pharmacological strategies for migraine prophylaxis , distinguishing between episodic and chronic forms of the condition. The authors evaluate traditional oral therapies such as beta-blockers , topiramate , and amitriptyline , noting that while effective for episodic cases, they often carry significant side effects. A major focus is placed on recent therapeutic advancements, specifically monoclonal antibodies and gepants that target the CGRP pathway. These newer treatments demonstrate high tolerability and effectiveness, even for patients suffering from medication overuse headache or those who failed previous therapies. Additionally, onabotulinumtoxinA is highlighted as a proven option specifically for chronic migraine management. The text concludes that these modern interventions offer a superior safety profile and rapid onset of action compared to conventional medications.